Communication Facilitator in ICU Economically Feasible

Share this content:
Communication Facilitator in ICU Economically Feasible
Communication Facilitator in ICU Economically Feasible

WEDNESDAY, Dec. 14, 2016 (HealthDay News) -- Staffing the intensive care unit (ICU) with a communication facilitator is economically feasible, according to research published in the December issue of the Annals of the American Thoracic Society.

Nita Khandelwal, M.D., from Harborview Medical Center in Seattle, and colleagues examined the economic feasibility of staffing ICUs with a communication facilitator using data from a randomized trial. One hundred thirty-five patients were admitted to the ICU at a single hospital with predicted mortality of ≥30 percent and a surrogate decision maker. The authors examined the differences in ICU total and direct variable costs for intervention and control patients.

The researchers observed a reduction in total and average daily ICU costs with the intervention (P = 0.02 and 0.006, respectively). Families of survivors spent less time per encounter with facilitators than families of decedents (mean, 25 versus 36 minutes), despite more contacts. After incorporating facilitator costs, simulation projected maximal weekly savings with a 1.0 full-time equivalent facilitator and 15 percent predicted ICU mortality (total weekly ICU savings of $58.4 k; weekly direct variable savings, $5.7k).

"Adding a full-time trained communication facilitator in the ICU may improve the quality of care while simultaneously reducing short-term (direct variable) and long-term (total) health care costs," the authors write. "This intervention is likely to be more cost-effective in a lower-mortality population."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »